J. Hallas

First name
J.
Last name
Hallas
Rivero-Ferrer, E. ., Olesen, M. ., Plana, E. ., Aguado, J. ., Saigi-Morgui, N. ., Rubino, A. ., … Rebordosa, C. . (2022). Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clin Drug Investig. http://doi.org/10.1007/s40261-022-01120-2
Gaist, D. ., Rodriguez, L. A., Huerta, C. ., Hallas, J. ., & Sindrup, S. H. (2001). Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidemiology.
Kuiper, J. G., van Herk-Sukel, M. P. P., Castellsague, J. ., Pottegard, A. ., Berglind, I. A., Dedman, D. ., … Perez-Gutthann, S. . (2018). Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs Real World Outcomes. http://doi.org/10.1007/s40801-018-0133-1
Margulis, A. V., Linder, M. ., Arana, A. ., Pottegard, A. ., Berglind, I. A., Bui, C. L., … Hallas, J. . (2018). Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. PLoS One. http://doi.org/10.1371/journal.pone.0204456
Castellsague, J. ., Kuiper, J. G., Pottegard, A. ., Berglind, A. ., Dedman, D. ., Gutierrez, L. ., … Perez-Gutthann, S. . (2018). A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study). Clin Epidemiol. http://doi.org/10.2147/clep.s146442
Phiri, K. ., Hallas, J. ., Linder, M. ., Margulis, A. ., Suehs, B. ., Arana, A. ., … Seeger, J. . (2021). A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Curr Med Res Opin. http://doi.org/10.1080/03007995.2021.1891035
Arana, A. ., Pottegard, A. ., Kuiper, J. G., Booth, H. ., Reutfors, J. ., Calingaert, B. ., … Perez-Gutthann, S. . (2021). Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical Epidemiology. http://doi.org/https://doi.org/10.2147/CLEP.S331287
Hoffman, V. ., Hallas, J. ., Linder, M. ., Margulis, A. V., Suehs, B. T., Arana, A. ., … Seeger, J. D. (2021). Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-021-01095-7